Second tests for Chlamydia trachomatis and Neisseria gonorrhoeae

Sexually Transmitted Infections

Volumn 88, Issue 7, 2012, Pages 497-

  Skidmore, Sue ^a   Corden, Sally ^b  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; DIAGNOSTIC PROCEDURE; HUMAN; LETTER; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE;

CHLAMYDIA TRACHOMATIS; GONORRHEA; HUMANS; LYMPHOGRANULOMA VENEREUM; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; NEISSERIA GONORRHOEAE; POLYMERASE CHAIN REACTION;

EID: 84871368303     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050781     Document Type: Letter

References (4)

1. Hopkins MJ, Smith G, Hart I, et al. Screening tests for Chlamydia trachomatis or Neisseria gonorrhoeae using the cobas 4800 PCR system do not require a second test to confirm: an audit of patients issued with equivocal results at a sexual health clinic in the Northwest of England, UK. Sex Transm Infect Published Online First 1 Jun 2012. doi:10.1136/sextrans-2012-050535.
2. Schachter J, Chernesky MA. Routine confirmation of positive nucleic acid amplification test results for Neisseria gonorrhoeae is not necessary. J Clin Microbiol 2012;50:208.
3. Tabrizi SN, Hjelmevoll SO, Garland SM, et al. Reply to above. J Clin Microbiol 2012; 50:209-10.
4. Schachter J, Chow JM, Howard H, et al. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J Clin Microbiol 2006;44:2512-17. (Pubitemid 44092420)